Nitric-oxide-donating NSAIDs as agents for cancer prevention

Trends in Molecular Medicine
Basil Rigas, Khosrow Kashfi

Abstract

Nitric-oxide-donating nonsteroidal anti-inflammatory drugs (NO-NSAIDs), which consist of an NSAID with an NO-donating moiety covalently attached to it, promise to contribute significantly towards the development of effective chemoprevention strategies against cancer. NO-NSAIDs inhibit the growth of cultured cancer cells 10-6000-fold more potently than their parent NSAIDs and prevent colon cancer in animal tumor models. Clinical data indicate that they are extremely safe. Mechanistically, NO-aspirin, the best-studied NO-NSAID, has pleiotropic effects on cell signaling (it inhibits Wnt signaling, induces nitric oxide synthase and NF-kappaB activation and induces cyclooxygenase-2 expression), and this mechanistic redundancy might be central to its mode of action against cancer. The apparent safety and superior efficacy of NO-NSAIDs makes them promising chemopreventive agents against cancer.

References

Oct 29, 1998·The New England Journal of Medicine·T TakayamaY Niitsu
Aug 4, 1999·Trends in Pharmacological Sciences·P del SoldatoA Pinto
Jun 30, 2000·The New England Journal of Medicine·G SteinbachG Kelloff
Jun 9, 2001·Biochemical and Biophysical Research Communications·C LavagnaP Rampal
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Lawrence J Marnett, Raymond N DuBois
Feb 21, 2002·Journal of the National Cancer Institute·Michael J ThunCarlo Patrono
Apr 9, 2002·Prostaglandins & Other Lipid Mediators·Chatargy S KazaBasil Rigas
Jun 13, 2002·European Journal of Clinical Investigation·Irma M Oving, Hans C Clevers
Sep 5, 2002·Nature Reviews. Immunology·Ann Richmond
Nov 27, 2002·Cancer Investigation·Yaser RayyanBasil Rigas
Dec 20, 2002·Gastroenterology Clinics of North America·Edward Giovannucci
Feb 18, 2003·Fundamental & Clinical Pharmacology·John L Wallace, Piero Del Soldato
Apr 10, 2003·Free Radical Biology & Medicine·Lorne J HofsethCurtis C Harris

❮ Previous
Next ❯

Citations

Sep 10, 2005·Apoptosis : an International Journal on Programmed Cell Death·F FabbriW Zoli
May 16, 2006·Apoptosis : an International Journal on Programmed Cell Death·Marco RosettiWainer Zoli
Jun 24, 2006·Nature Reviews. Cancer·Dai FukumuraRakesh K Jain
Jun 23, 2009·The Journal of Biological Chemistry·Christopher J MacDonaldGrace Chao Yeh
Jan 29, 2013·Carcinogenesis·Amy J BurkeSharon A Glynn
Aug 29, 2007·Acta Pharmacologica Sinica·Vassiliki KozoniBasil Rigas
Dec 27, 2007·Acta Pharmacologica Sinica·Naveena B Janakiram, Chinthalapally V Rao
May 1, 2009·Immunotherapy·Hiroyasu YasudaKazuhiro Yanagihara
Nov 30, 2012·Future Medicinal Chemistry·Naveena B Janakiram, Chinthalapally V Rao
Dec 13, 2006·Future Oncology·Elizabeth E Half, Nadir Arber
Nov 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jianjun GaoBasil Rigas
Jun 6, 2014·BioMed Research International·Hitoshi Ishiguro, Takashi Kawahara
Mar 26, 2011·Cancer Prevention Research·Michael A McIlhattonRichard Fishel
Feb 14, 2008·Expert Opinion on Therapeutic Targets·Darren D Browning
Jul 18, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Niharika NathKhosrow Kashfi
Jul 19, 2005·Expert Opinion on Investigational Drugs·Roberto ScatenaBruno Giardina
Nov 1, 2005·Expert Opinion on Investigational Drugs·Brendan J R Whittle
Feb 25, 2009·Expert Opinion on Pharmacotherapy·Elizabeth Half, Nadir Arber
Dec 29, 2015·DNA Repair·Kyeryoung LeeWinfried Edelmann
Aug 3, 2010·Cancer Letters·Mitali ChattopadhyayKhosrow Kashfi
Mar 30, 2010·Plant Physiology and Biochemistry : PPB·Fiona R Saunders, Heather M Wallace
Nov 28, 2009·Best Practice & Research. Clinical Gastroenterology·Peter R HoltSeetal Mewar
Sep 5, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Iris GehrkeKarl-Anton Kreuzer
May 20, 2008·Nitric Oxide : Biology and Chemistry·Basil Rigas, Jennie L Williams
Mar 10, 2016·Macromolecular Bioscience·Urara HasegawaAndré J van der Vlies
May 22, 2007·Biochemical and Biophysical Research Communications·Khosrow Kashfi, Basil Rigas
Apr 17, 2007·Experimental Neurology·Ennio EspositoGiuseppe Di Giovanni
Sep 23, 2006·Medicinal Research Reviews·Simone MocellinDonato Nitti
Apr 21, 2011·Journal of Cellular Physiology·Sanja MijatovicFerdinando Nicoletti
Nov 30, 2004·Biochemical and Biophysical Research Communications·Niharika NathKhosrow Kashfi
Apr 24, 2015·Basic & Clinical Pharmacology & Toxicology·Paolo FagoneFerdinando Nicoletti
Jul 12, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·James A Crowell
Jul 9, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mark A Hull
Jul 24, 2015·Journal of Medicinal Chemistry·Yingdong ZhuShengmin Sang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis